Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Other financing activities (2020 - 2024)

LifeStance Health (LFST) has disclosed Other financing activities for 4 consecutive years, with $1.8 million as the latest value for Q4 2024.

  • Quarterly Other financing activities changed N/A to $1.8 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2024, up 2117.07% year-over-year, with the annual reading at $1.8 million for FY2024, 867.02% up from the prior year.
  • Other financing activities for Q4 2024 was $1.8 million at LifeStance Health, up from $82000.0 in the prior quarter.
  • The five-year high for Other financing activities was $7.2 million in Q2 2022, with the low at -$1.4 million in Q4 2021.
  • Average Other financing activities over 4 years is $2.4 million, with a median of $1.1 million recorded in 2021.